Hemodynamics, fluids & transfusion

High–normal versus low–normal mean arterial pressure thresholds in critically ill patients: a systematic review and meta-analysis of randomized trials

Can J AnaesthPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

This updated systematic review and meta-analysis of RCTs found no differences in mortality, favourable neurologic outcome, or the need for renal replacement therapy between critically ill patients assigned to a high-normal vs low-normal MAP target.

Study context

Population
Critically ill patients (OHCA, distributive shock requiring vasopressors, septic shock, hepatorenal syndrome)
Participants
4,561 patients · 8 randomized controlled trials (RCTs)
Comparison
High-normal vs low-normal mean arterial pressure (MAP) threshold
Outcome
Mortality, high-normal vs low-normal MAP
Methodological detailsGRADE certainty assessment, Cochrane risk-of-bias 2 tool, Six databases searched from inception until 1 October 2022
  • GRADE certainty assessment
  • Cochrane risk-of-bias 2 tool
  • Six databases searched from inception until 1 October 2022

Pooled result

As reported in the abstract

Pooled RR for mortality (8 RCTs; 4,439 patients)

1.06

95% CI 0.99 to 1.14

Further pooled results

Favourable neurologic outcome, high-normal vs low-normal MAP

Pooled RR for favourable neurologic outcome (4 RCTs; 1,065 patients)
0.99 (95% CI, 0.90 to 1.08)
  • Moderate certainty

Need for RRT, high-normal vs low-normal MAP

RR for need for RRT (4 RCTs; 4,071 patients)
0.97 (95% CI, 0.87 to 1.08)
  • Moderate certainty

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

High–normal versus low–normal mean arterial pressure thresholds in critically ill patients: a systematic review and meta-analysis of randomized trials. Can J Anaesth. Published 2 June 2023. doi:10.1007/s12630-023-02494-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.